Third quarter and nine months results 2014
6th November 2014
AstraZeneca will announce third quarter & nine months results for 2014 on Thursday, 6th November with a scheduled Stock Exchange release time of 07:00GMT (08:00CET, 02:00AM EST). An analyst presentation of the results will take place at 12:00GMT (13:00CET, 07:00AM EST).
AstraZeneca Investor Day
18th November 2014, London
AstraZeneca will host an Investor Day for analysts and Investors to be held on Tuesday 18th November 2014. This will be an opportunity for Pascal Soriot and his management team to provide an updated view of AstraZeneca’s strategy and plans to return to growth and scientific leadership in our chosen areas.
Please contact us for more details or if you are planning to attend the conference.
If you are unable to join the event in person, the presentations will be accessible by live and recorded webcast and teleconference.
Investor Relations presentation
Download our presentation to review our latest financial information, product performance and see progress on our development pipeline of potential new medicines. Updated following our Q2 and half year results 2014.Investor Relations presentation (PDF 5076kb)
Second quarter and half year results 2014
Strategic Transaction with Almirall
American Society of Clinical Oncology
American Thoracic Society AstraZeneca Analyst briefing
Annual Report 2013
Our Annual Report provides a wide range of information about our global business and how we are working, both within the company and in partnership with others, to push the boundaries of science and deliver medicines that transform the lives of people around the world.
Currency guidance 2014
In order to help analysts and investors estimate the impact of changing exchange rates on sales and earnings, the Company provides an annual 'currency sensitivity guide', alongside the rates upon which its earnings guidance is based.
The latest guide, intended to help estimate the impact of currency movements for 2014, is an update of the 2013 guidance given in January 2013.
Keeping investors in touch
AstraZeneca Investor Relations iPad app
The AstraZeneca Investor Relations iPad app provides instant access to our latest news, webcasts and presentations, events and leadership videos.
Notifications will keep you up to date with the most recent updates from AstraZeneca and synchronise to your device for reference.